In a pandemic the pharmaceutical industry is hailed as a saviour; yet the industry is using the crisis to lock in its problematic, profit-maximising model. Pushing for public money with no-strings-attached, and stronger monopoly patent rules, the industry’s wish-list could restrict access to COVID-19 drugs and vaccines, prolonging the pandemic in the name of profit. Control over prices and access must not be left in private hands: health is a human right.
“The EU has worked itself into a political straitjacket, such that few of its member nations would dare hold a referendum on continued membership. This cannot be healthy for the EU or for Europe. The […]
Günther Oettinger was as a three time EU commissioner notorious for his interventions for international corporations and German industrial interests. Now he is working as a lobbyist for the tobacco companies according to the EU […]
The self-serving arguments used by big pharma lobbyists at meetings with the European Commission to defend monopoly intellectual property rights on vaccines are demonstrably false. Corporate Europe Observatory has uncovered new documents from December 2020 […]
Copyright © 2023 | MH Magazine WordPress Theme by MH Themes
Be the first to comment